Chemical activators of the protein encoded by C12orf62 can modulate its activity through various intracellular signaling pathways. For instance, Forskolin and Isoproterenol act to raise intracellular cAMP levels, subsequently activating protein kinase A (PKA). Activation of PKA can lead to the phosphorylation of target proteins, which includes the potential activation of the protein of interest if it serves as a substrate for PKA. Ionomycin functions by increasing the concentration of intracellular calcium, which can activate calmodulin-dependent kinases (CaMKs). These kinases then have the capacity to phosphorylate and thereby regulate the activity of a broad suite of proteins, including the protein encoded by C12orf62, provided it is sensitive to calcium signaling. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which has a similar potential to phosphorylate and modulate the activity of the protein if it is within the scope of PKC's targets.
Further along the diverse spectrum of signaling cascades, Insulin can trigger the phosphoinositide 3-kinase (PI3K)/Akt pathway, which is known for its role in regulating a myriad of cellular processes through phosphorylation events. If the protein encoded by C12orf62 falls under the umbrella of substrates phosphorylated by Akt, its activation status can be influenced by insulin signaling. Epidermal Growth Factor (EGF) initiates the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway, which might engage the protein in question as part of its downstream regulatory targets. Hydrogen Peroxide, through its role as a reactive oxygen species, can exert changes in cellular signaling through oxidative modification of proteins, which may alter the phosphorylation status and activity of the protein. Meanwhile, S-Nitroso-N-acetylpenicillamine (SNAP) releases nitric oxide, increasing cGMP, which activates protein kinase G (PKG) that can phosphorylate a plethora of proteins, potentially including this one. Lithium Chloride's inhibition of glycogen synthase kinase 3 beta (GSK-3β) can lead to the activation of proteins that are otherwise negatively regulated by GSK-3β, affecting the protein indirectly. BAY 11-7082's inhibition of the NF-κB pathway also offers a route to modulate protein activity, considering NF-κB's wide range of influence on cellular functions. Anisomycin, which activates stress-activated protein kinases, and Zinc Pyrithione, through the inhibition of tyrosine phosphatases, can both induce modifications in phosphorylation patterns that may impact the protein's activity. Each chemical mentioned exerts its influence through a distinct mechanism, but all converge on the possibility of altering the activation status of the protein encoded by C12orf62.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Raises intracellular calcium levels, possibly activating CaMKs which may phosphorylate and activate C12orf62 if calcium-sensitive. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which might phosphorylate and activate C12orf62 if it's a PKC substrate. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP and activates PKA, potentially leading to the phosphorylation and activation of C12orf62. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the PI3K/Akt pathway, possibly resulting in the phosphorylation and activation of C12orf62 if it is within the pathway's downstream effects. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As a reactive oxygen species, it can modulate signaling pathways and may alter the activation state of C12orf62 through redox mechanisms. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Releases nitric oxide, which may increase cGMP levels and activate PKG potentially resulting in the activation of C12orf62. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β potentially leading to the activation of C12orf62 if GSK-3β negatively regulates this protein. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB activation, possibly leading to the activation of C12orf62 through indirect pathways involving NF-κB signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases which may include C12orf62 in their activation targets if it responds to stress signals. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Inhibits tyrosine phosphatases possibly leading to increased tyrosine phosphorylation and activation of C12orf62 if it's regulated by such phosphorylation. | ||||||